Text Size
14 studies found for:    Open Studies | "Thymus Neoplasms"

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Recruiting Sunitinib for Advanced Thymus Cancer Following Earlier Treatment
Conditions: Thymoma;   Thymus Neoplasms
Intervention: Drug: Sunitinib
2 Unknown † Neoadjuvant Chemotherapy for Locally Advanced Thymic Cancer
Condition: Locally Advanced Stage III or IV Thymic Cancer
Intervention: Drug: neoadjuvant docetaxel/cisplatin
3 Recruiting Esophageal Sparing Intensity-modulated Radiation Therapy (IMRT) for Locally-Advanced Thoracic Malignancies
Conditions: Non Small Cell Lung Cancer;   Small Cell Lung Cancer;   Thymoma;   Thymus Neoplasms
Intervention: Radiation: Esophageal sparing IMRT
4 Recruiting Molecular Analysis of Thoracic Malignancies
Conditions: Thymus Cancer;   Thymoma;   Thymic Carcinoma;   Lung Cancer;   Carcinoma, Non-Small-Cell Lung;   Mesothelioma
Intervention:
5 Recruiting A Phase II Study of Amrubicin in Relapsed or Refractory Thymic Malignancies
Conditions: Thymoma;   Thymus Cancer;   Thymic Carcinoma
Intervention: Drug: Amrubicin
6 Recruiting Heated Chemotherapy for Cancers That Have Spread to the Chest Cavity
Conditions: Pleural Metastases;   Breast Cancer;   Colon Cancer;   Ovarian Cancer;   Uterine Cancer;   Renal Cell Cancer;   Thymic Cancer
Intervention: Procedure: Surgical debulking and Intrathoracic Hyperthermic Chemotherapy
7 Recruiting Pilot Study of Allogeneic Tumor Cell Vaccine With Metronomic Oral Cyclophosphamide and Celecoxib in Patients Undergoing Resection of Lung and Esophageal Cancers, Thymic Neoplasms, and Malignant Pleural Mesotheliomas
Conditions: Lung Cancer;   Esophageal Cancer;   Malignant Pleural Mesothelioma;   Thymoma;   Thymic Carcinoma
Interventions: Biological: Allogeneic Tumor Cell Vaccine (K562);   Drug: Celecoxib;   Drug: cyclophosphamide
8 Recruiting A Phase 1/2 Study of PXD101 (Belinostat) in Combination With Cisplatin, Doxorubicin and Cyclophosphamide in the First Line Treatment of Advanced or Recurrent Thymic, Malignancies
Conditions: Thymoma;   Thymic Carcinoma
Interventions: Drug: Belinostat;   Drug: Cisplatin;   Drug: Cyclophosphamide;   Drug: Doxorubicin
9 Recruiting Molecular Profiling and Targeted Therapy for Advanced Non-Small Cell Lung Cancer, Small Cell Lung Cancer, and Thymic Malignancies
Conditions: Carcinoma, Non-Small-Cell Lung;   Carcinoma, Small Cell Lung;   Carcinoma, Thymic
Interventions: Drug: AZD;   Drug: MK-2206;   Drug: Lapatinib;   Drug: Erlotinib;   Drug: Sunitinib;   Procedure: Molecular Profiling
10 Recruiting Nonmyeloablative Allogeneic Transplant
Conditions: Aplastic Anemia;   Paroxysmal Nocturnal Hemoglobinuria;   Acute Myelogenous Leukemia;   Acute Lymphocytic Leukemia;   Myelodysplastic Syndrome;   Chronic Myelogenous Leukemia;   Chronic Lymphocytic Leukemia;   Hodgkin's Lymphoma;   Non-Hodgkin's Lymphoma;   Mantle Cell Lymphoma;   Multiple Myeloma;   Waldenstrom Macroglobulinemia;   Breast Cancer;   Renal Cell Carcinoma;   Melanoma;   Sarcoma;   Ovarian Cancer;   Thymoma
Intervention: Procedure: Nonmyeloablative Allogeneic Transplant
11 Recruiting Phase II Study Of Oral PHA-848125AC In Patients With Thymic Carcinoma
Condition: Thymic Carcinoma
Intervention: Drug: Milciclib Maleate
12 Recruiting Preoperative Treatment of Patients With High Risk Thymoma
Condition: Thymoma
Interventions: Drug: cisplatin and etoposide;   Procedure: Surgical Resection;   Radiation: Concurrent Radiotherapy
13 Recruiting Chemotherapy Plus Cetuximab Followed by Surgical Resection in Patients With Locally Advanced or Recurrent Thymoma or Thymic Carcinoma
Conditions: Thymoma;   Thymic Carcinoma.;   Clinical Masaoka Stage II-IVA
Intervention: Drug: Cetuximab, Cisplatin, Doxorubicin & Cyclophosphamide
14 Recruiting Study Of Oral PHA-848125AC In Patients With Malignant Thymoma Previously Treated With Multiple Lines Of Chemotherapy
Condition: Malignant Thymoma
Intervention: Drug: Milciclib Maleate
To Top

† Indicates status has not been verified in more than two years